Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R King

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 20, 2016
The dose-response of salvage radiotherapy following radical prostatectomy: A systematic review and meta-analysisChristopher R King
Seminars in Radiation Oncology|June 15, 2013
Adjuvant versus salvage radiotherapy for high-risk prostate cancer patientsChristopher R King
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Adjuvant versus salvage radiotherapy after prostatectomy: the apple versus the orangeChristopher R King
International Journal of Radiation Oncology, Biology, Physics|February 1, 2011
Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?Christopher R King
Brachytherapy|April 6, 2004
LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological modelsChristopher R King
International Journal of Radiation Oncology, Biology, Physics|July 17, 2012
The timing of salvage radiotherapy after radical prostatectomy: a systematic reviewChristopher R King
International Journal of Radiation Oncology, Biology, Physics|September 9, 2009
Don't squeeze hypofractionated schedules into too-short overall timesJack Fowler, Christopher R King
The Journal of Urology|April 7, 2016
Re: Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?: L. J. Sokoll, Z. Zhang, D. W. Chan, A. C. Reese, T. J. Bivalacqua, A. W. Partin and P. C. Walsh J Urol 2016;195:330-336Allen Edel, Christopher R King
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
Improved outcomes with higher doses for salvage radiotherapy after prostatectomyChristopher R King, Michael T Spiotto
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trialEllen A Wiegner, Christopher R King
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 20, 2016
The dose-response of salvage radiotherapy following radical prostatectomy: A systematic review and meta-analysisChristopher R King
Seminars in Radiation Oncology|June 15, 2013
Adjuvant versus salvage radiotherapy for high-risk prostate cancer patientsChristopher R King
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Adjuvant versus salvage radiotherapy after prostatectomy: the apple versus the orangeChristopher R King
International Journal of Radiation Oncology, Biology, Physics|February 1, 2011
Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?Christopher R King
Brachytherapy|April 6, 2004
LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological modelsChristopher R King
International Journal of Radiation Oncology, Biology, Physics|July 17, 2012
The timing of salvage radiotherapy after radical prostatectomy: a systematic reviewChristopher R King
International Journal of Radiation Oncology, Biology, Physics|September 9, 2009
Don't squeeze hypofractionated schedules into too-short overall timesJack Fowler, Christopher R King
The Journal of Urology|April 7, 2016
Re: Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?: L. J. Sokoll, Z. Zhang, D. W. Chan, A. C. Reese, T. J. Bivalacqua, A. W. Partin and P. C. Walsh J Urol 2016;195:330-336Allen Edel, Christopher R King
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
Improved outcomes with higher doses for salvage radiotherapy after prostatectomyChristopher R King, Michael T Spiotto
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trialEllen A Wiegner, Christopher R King
Pageof 12